These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31960603)

  • 1. Anabolic and lipolytic actions of beta
    Hostrup M; Jacobson GA; Jessen S; Lemminger AK
    Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The salmeterol anomaly and the need for a urine threshold.
    Jacobson GA; Hostrup M
    Drug Test Anal; 2022 Jun; 14(6):997-1003. PubMed ID: 32314556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbutaline: level the playing field for inhaled β
    Jacobson GA; Hostrup M
    Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
    Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
    Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
    Riiser A; Stensrud T; Stang J; Andersen LB
    Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sports doping: emerging designer and therapeutic β2-agonists.
    Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
    Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
    Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective disposition of (R)-salmeterol and (S)-salmeterol in urine following inhaled dosing and application to doping control.
    Jacobson GA; Hostrup M; Narkowicz CK; Nichols DS; Haydn Walters E
    Drug Test Anal; 2017 Aug; 9(8):1262-1266. PubMed ID: 28033454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta
    Hostrup M; Narkowicz CK; Habib S; Nichols DS; Jacobson GA
    Drug Test Anal; 2019 Jul; 11(7):1048-1056. PubMed ID: 30836453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
    Kalsen A; Hostrup M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β
    Hudzik TJ; Patel M; Brown A
    Drug Test Anal; 2021 Feb; 13(2):261-267. PubMed ID: 33369180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond bronchodilation: Illuminating the performance benefits of inhaled beta
    Hostrup M; Jessen S
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14567. PubMed ID: 38268072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
    Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
    Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.